Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 49 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Current and future targets of antiviral therapy in the hepatitis C virus life cycleEyre, N.; Helbig, K.; Beard, M.
2013Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virusMcCartney, E.; Helbig, K.; Narayana, S.; Eyre, N.; Aloia, A.; Beard, M.
2015Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.Aloia, A.; Eyre, N.; Black, S.; Bent, S.; Gaeguta, A.; Guo, Z.; Narayana, S.; Chase, R.; Locarnini, S.; Carr, J.; Howe, J.; Beard, M.
2014Dynamic imaging of the hepatitis C virus NS5A protein during a productive infectionEyre, N.; Fiches, G.; Aloia, A.; Helbig, K.; McCartney, E.; McErlean, C.; Li, K.; Aggarwal, A.; Turville, S.; Beard, M.; Diamond, M.S.
2015Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responsesCalvert, J.; Helbig, K.; Dimasi, D.; Cockshell, M.; Beard, M.; Pitson, S.; Bonder, C.; Carr, J.
2010Impaired methylation as a novel mechanism for proteasome suppression in liver cellsOsna, N.; White, R.; Donohue, T.; Beard, M.; Tuma, D.; Kharbanda, K.
2008A screening method for identifying disruptions in interferon signaling reveals HCVNS3/4a disrupts Stat-1 phosphorylationHelbig, K.; Yip, L.; McCartney, E.; Eyre, N.; Beard, M.
2013Bioinformatics methods for the analysis of hepatitis virusesMoriconi, F.; Beard, M.; Yuen, L.
2011Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infectionBerzsenyi, M.; Roberts, S.; Preiss, S.; Woollard, D.; Beard, M.; Skinner, N.; Bowden, D.; Visvanathan, K.
2011Tumour necrosis factor alpha (TNF-α) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-α to activate nuclear factor κB and reduced sphingosine kinase-1 activityWati, S.; Rawlinson, S.; Ivanov, R.; Dorstyn, L.; Beard, M.; Jans, D.; Pitson, S.; Burrell, C.; Li, P.; Carr, J.